Doctors Manufacturing Pharma Specialization 
Pharmaceutical Technology
JUNE 29, 2022
For hundreds of years, we have found myriad uses for microbial enzymes in manufacturing – from food, drink, and household products to a range of industrial applications. Meanwhile, the pharma industry is undergoing somewhat of a transformation itself. Developing best-in-class speciality enzymes.
PM360
JULY 26, 2022
These results suggest pharma marketers have room to explore new ways to help close educational gaps and support LGBTQ+ patients in accessing preventive care. And 67% of LGBTQ+ patients said their doctor never brought up cancer screenings, including 48% of LGBTQ+ patients over 45 years old.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
OCTOBER 13, 2023
Is the metaverse a worthwhile investment for pharma? So, should pharma be preparing for a future where this is the case? For Specialized Care: We’ve heard heroic stories of patients living in “Health Deserts” driving almost a whole day to receive specialized oncology care because they had no options in their local communities.
Evolve Your Success
MARCH 14, 2023
From treating doctors and providers as partners to viewing your role as an extension to help others in that partnership, he shows how far one can go in the industry when you know how to communicate. . Also, I was like, “I probably don’t want to be a doctor because they have to go to school for a long time.” I was an athlete.
pharmaphorum
SEPTEMBER 24, 2022
The doctor will see you now. While this promises unrivalled convenience for users in the future, drug manufacturers will need to reconsider how to fit patient support programs into their patients’ lives. That special moment to engage the patient when it’s time to take one’s meds is now gone. You’re reading a book.
pharmaphorum
NOVEMBER 10, 2022
And so, with Bartosz Arlukwiez, chair of the special committee on beating cancer (BECA) of the European Parliament, unable to attend (although he did provide a pre-recorded message of apology), the panel proceeded into discussions. The responsibilities of pharma. Pharma needs to continue to invest in M&D.
pharmaphorum
JANUARY 9, 2023
Deglobalisation has, however, not gone away and 2023 will see acceleration of this trend, manifested in the following: Lower- and middle-income countries (LMICs) were exposed to medicine supply issues because of the pandemic, as they lacked both funds to secure supply and their own manufacturing capacity.
Expert insights. Personalized for you.
118 
Let's personalize your content